Morgans rates M7T as Initiation of coverage with Hold (3) -
Mach7 Technologies first-half result met Morgans' estimates, the company reporting maiden positive cash flow, on track with guidance.
A key contract win from Advocate Aurora Health was the main driver, thanks to the booking of $4m in software licence fees.
Management reports a solid pipeline, but the broker says much will come down to the timing of contract execution from here and expects a weaker second half.
Morgans initiates coverage with a Hold rating and target of $1.16.
So they start at a hold, even though you would make 40% buying here if it hits their target!
What clowns.
Morgans rates M7T as Initiation of coverage with Hold (3) -...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $68.14M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 29.0¢ | $64.13K | 220.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 66304 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 2890 | 1 |
View Market Depth
| Last trade - 15.44pm 19/09/2025 (20 minute delay) ? |
| M7T (ASX) Chart |